Arixtra fondaparinux: Phase IIb

In a double-blind European Phase IIb study of Arixtra in 1,147 patients with ACS, Arixtra was as effective

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE